federico innocenti
University of North Carolina at Chapel Hill
Chapel Hill, United States
Associate Editor
Pharmacogenetics and Pharmacogenomics
University of North Carolina at Chapel Hill
Chapel Hill, United States
Associate Editor
Pharmacogenetics and Pharmacogenomics
University of Birmingham
Birmingham, United Kingdom
Associate Editor
Inflammation Pharmacology
United Arab Emirates University
Al-Ain, United Arab Emirates
Associate Editor
Translational Pharmacology
University of Hertfordshire
Hatfield, United Kingdom
Associate Editor
Neuropharmacology
University of Michigan
Ann Arbor, United States
Associate Editor
Inflammation Pharmacology
Alembic Pharmaceuticals (India)
Vadodara, India
Associate Editor
Experimental Pharmacology and Drug Discovery
The University of Texas Health Science Center at Tyler
Tyler, United States
Associate Editor
Pharmacology of Ion Channels and Channelopathies
Florey Institute of Neuroscience and Mental Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne
Parkville, Australia
Associate Editor
Translational Pharmacology
Institut National de la Santé et de la Recherche Médicale (INSERM)
Paris, France
Associate Editor
Obstetric and Pediatric Pharmacology
University of Kansas Medical Center Research Institute
Kansas City, United States
Associate Editor
Gastrointestinal and Hepatic Pharmacology
Memorial Sloan Kettering Cancer Center
New York, United States
Associate Editor
Renal Pharmacology
Karolinska Institutet (KI)
Solna, Sweden
Associate Editor
Inflammation Pharmacology
Luxembourg Institute of Health
Luxembourg, Luxembourg
Associate Editor
Pharmacology of Anti-Cancer Drugs
Faculty of Pharmaceutical Sciences, Khon Kaen University
Khon Kaen, Thailand
Associate Editor
Inflammation Pharmacology
College of Medicine and Science, Mayo Clinic
Rochester, United States
Associate Editor
Renal Pharmacology
College of Medicine, University of Illinois at Peoria
Peoria, United States
Associate Editor
Experimental Pharmacology and Drug Discovery